Fluent Baldor Black Hybrid Vape Cartridge [0.5g]

(3 customer reviews)


Upbeat, Sativa-Dominant Hybrid

Baldor is produced from a hybrid Cannabis sativa and Cannabis indica plant and has a ratio of 60:1 THC:CBD. Baldor balances full-body relaxation with gentle cerebral invigoration. Novice and veteran consumers alike enjoy the well-rounded effects of Baldor, which ease gently into a calm euphoria. As a hybrid, Baldor leans generally leans on the Sativa-side as more uplifting and clear-headed. With a sweet berry aroma, Baldor delivers swift relief without heavy sedation. This makes Baldor a popular daytime medication for patients treating pain, depression, nausea, and other qualifying conditions.

Current medical literature supports the use of THC rich products for the treatment of all conditions approved for medical cannabis.

Strain: Blue Dream

CBD Content: Approximately 1%

THC Content: Approximately 90%

Dosing Units: Each vaporizer 450 mg cartridge contains 3 mg THC/inhalation

Total Doses: Approximately 150 inhalations per cartridge

Sold By: Fluent

Categories: Vape Cartridges, Sativa Dominant, Hybrid

Leave Your Review: Write A Review

Out of stock

3 reviews for Fluent Baldor Black Hybrid Vape Cartridge [0.5g]

  1. Ann Young

    Its still the best, and I’ve tried most of them!

  2. Ann Young

    I love it, it’s my all time favorite vape! You get one hell of a buzz, at the same time it relaxes you, it changes your mood in a good way, only vape crt I buy!

  3. flapp

    Takes a minute to get used to as can come on loud. After that, good, alert strain. may make you a bit edgy

Add a review

Your email address will not be published. Required fields are marked *

Product Description

“Vaping” is short for “vaporization”. Effects are felt immediately and unlike smoking, no combustion or burning takes place. Portable vaporizers are very discreet, as vapor dissipates quickly with minimal odor.

Patients are recommended to initiate treatment on the evening of Day 1 with 1-3 inhalation sessions. Each session consists of 1-2 draws that are relatively shallow (1-3 seconds) and held for about 5 seconds before exhaling. After 5-10 minutes, patients reassess symptoms.

If symptoms have improved or subsided, no additional sessions are needed and patients take the next dose on the morning of Day 2.

Cash & CanPay Accepted

Baldor® is contraindicated in patients:

• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Baldor®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.